MedTrace Logo

Exercise-Modulated Cognitive Hormones

NCT07341568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-01-14

No results posted yet for this study

Summary

Investigating the influence of a 12-week exercise regimen structured thrice weekly on cognitive capacity, and related hormones like Leptin, Irisin, BDNF hormones, antioxidant status, and inflammatory cytokines, whether these modulations potentially enhance neuroprotection and mitigate age-related cognitive impairment among healthy adults.

Conditions

Sponsors & Collaborators

  • King Saud University

    lead OTHER

Principal Investigators

  • Sami Gabr · Medical Microbiology Dept, ImmunityUnit,Faculty of Medicine, Mansoura University, Egypt

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-15
Primary Completion
2025-10-30
Completion
2025-11-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07341568 on ClinicalTrials.gov